Beneficial effect of lamivudine for hepatitis B transplant recipients.

about

Beneficial effect of lamivudine for hepatitis B transplant recipients.

Item

http://www.wikidata.org/entity/Q43988925

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@en

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@nl

type

Item

label

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@en

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@nl

prefLabel

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@en

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@nl

P1476

Beneficial effect of lamivudine for hepatitis B transplant recipients.

@en

P2093

David Mutimer

http://www.w3.org/2001/XMLSchema#string

P2860

Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis.

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

Natural history and prognostic factors for chronic hepatitis type B

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection.

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.

Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.

P304

440-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1053/JLTS.2002.32987

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11367362

http://www.w3.org/2001/XMLSchema#string

P698

12004343

http://www.w3.org/2001/XMLSchema#string